HQH ETF
TEKLA HEALTHCARE INVESTORS

| # | Ticker ↕ | Name ↕ | Weight ↓ | Shares ↕ | Mkt Value ↕ | Share Chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc | 6.44% | - | - | •••••• | •••••••• | •••••••• |
| 2 | AMGN | Amgen Inc | 5.97% | - | - | •••••• | •••••••• | •••••••• |
| 3 | REGN | Regeneron Pharmaceuticals Inc | 5.91% | - | - | •••••• | •••••••• | •••••••• |
| 4 | VRTX | Vertex Pharmaceuticals Inc | 3.96% | - | - | •••••• | •••••••• | •••••••• |
| 5 | LLY | Eli Lilly & Co | 3.57% | - | - | •••••• | •••••••• | •••••••• |
| 6 | BMRN | BioMarin Pharmaceutical Inc | 2.92% | - | - | •••••• | •••••••• | •••••••• |
| 7 | ALNY | Alnylam Pharmaceuticals Inc | 2.77% | - | - | •••••• | •••••••• | •••••••• |
| 8 | UNH | UnitedHealth Group Inc | 2.77% | - | - | •••••• | •••••••• | •••••••• |
| 9 | GVMXX | State Street Global Advisors | 2.23% | - | - | •••••• | •••••••• | •••••••• |
| 10 | ABT | Abbott Laboratories | 2.05% | - | - | •••••• | •••••••• | •••••••• |
| 11 | BNTX | BioNTech SE | 2.02% | - | - | •••••• | •••••••• | •••••••• |
| 12 | ARGX | Argenx SE | 1.84% | - | - | •••••• | •••••••• | •••••••• |
| 13 | SRPT | Sarepta Therapeutics Inc | 1.81% | - | - | •••••• | •••••••• | •••••••• |
| 14 | SMMT | Summit Therapeutics Inc | 1.70% | - | - | •••••• | •••••••• | •••••••• |
| 15 | IM8N | Insmed Inc | 1.69% | - | - | •••••• | •••••••• | •••••••• |
| 16 | ABBV | AbbVie Inc | 1.63% | - | - | •••••• | •••••••• | •••••••• |
| 17 | ASND | Ascendis Pharma A/S | 1.48% | - | - | •••••• | •••••••• | •••••••• |
| 18 | TMO | Thermo Fisher Scientific Inc | 1.41% | - | - | •••••• | •••••••• | •••••••• |
| 19 | MDT | Medtronic PLC | 1.33% | - | - | •••••• | •••••••• | •••••••• |
| 20 | NBIX | Neurocrine Biosciences Inc | 1.33% | - | - | •••••• | •••••••• | •••••••• |
HQH ETF All Holdings
HQH holdings total 102 positions. The top 10 holdings account for 38.6% of the fund, led by Gilead Sciences Inc at 6.4%, Amgen Inc at 6.0%, Regeneron Pharmaceuticals Inc at 5.9%.
HQH portfolio concentration is moderate, with the top 10 representing 38.6% of total assets. The largest sector exposure is Unknown at 91.6%.
HQH sector allocation provides a detailed breakdown. HQH overlap tool shows how holdings compare to other funds in your portfolio.
HQH ETF Holdings
102 of 102 holdings
- 1
Gilead Sciences Inc
GILDUnknown6.44% - 2
Amgen Inc
AMGNUnknown5.97% - 3
Regeneron Pharmaceuticals Inc
REGNUnknown5.91% - 4
Vertex Pharmaceuticals Inc
VRTXUnknown3.96% - 5
Eli Lilly & Co
LLYUnknown3.57% - 6
BioMarin Pharmaceutical Inc
BMRNUnknown2.92% - 7
Alnylam Pharmaceuticals Inc
ALNYUnknown2.77% - 8
UnitedHealth Group Inc
UNHUnknown2.77% - 9
State Street Global Advisors
GVMXXUnknown2.23% - 10
Abbott Laboratories
ABTUnknown2.05% - 11
BioNTech SE
BNTXUnknown2.02% - 12
Argenx SE
ARGXUnknown1.84% - 13
Sarepta Therapeutics Inc
SRPTUnknown1.81% - 14
Summit Therapeutics Inc
SMMTUnknown1.70% - 15
Insmed Inc
IM8NUnknown1.69% - 16
AbbVie Inc
ABBVUnknown1.63% - 17
Ascendis Pharma A/S
ASNDUnknown1.48% - 18
Thermo Fisher Scientific Inc
TMOUnknown1.41% - 19
Medtronic PLC
MDTUnknown1.33% - 20
Neurocrine Biosciences Inc
NBIXUnknown1.33% - 21
Intuitive Surgical Inc
ISRGUnknown1.24% - 22
Cytokinetics Inc
CYTKUnknown1.21% - 23
Merck & Co Inc
MRKUnknown1.20% - 24
Illumina Inc
ILMNUnknown1.19% - 25
uniQure NV
QUREUnknown1.18% - 26
Ultragenyx Pharmaceutical Inc
RAREUnknown1.13% - 27
Becton Dickinson & Co
BDXUnknown1.12% - 28
Elevance Health Inc
ELVUnknown1.05% - 29
Immunovant Inc
IMVTUnknown1.00% - 30
AstraZeneca PLC
AZNUnknown0.99% - 31
Akero Therapeutics Inc
AKROUnknown0.93% - 32
Tempus AI Inc
TEMUnknown0.86% - 33
Xenon Pharmaceuticals Inc
XENEUnknown0.85% - 34
Ionis Pharmaceuticals Inc
ISIUnknown0.84% - 35
Oculis Holding AG
OCSUnknown0.81% - 36
Zoetis Inc
ZTSUnknown0.79% - 37
Inspire Medical Systems Inc
INSPUnknown0.76% - 38
Arrowhead Pharmaceuticals Inc
ARWRUnknown0.69% - 39
Arcutis Biotherapeutics Inc
ARQTUnknown0.65% - 40
Amylyx Pharmaceuticals Inc
AMLXUnknown0.63% - 41
Denali Therapeutics Inc
DNLIUnknown0.60% - 42
Vaxcyte Inc
PCVXUnknown0.59% - 43
Bristol-Myers Squibb Co
BMYUnknown0.58% - 44
Guardant Health Inc
GHUnknown0.58% - 45
ARS Pharmaceuticals Inc
SPRYUnknown0.57% - 46
Sionna Therapeutics Inc
SIONUnknown0.57% - 47
GRAIL Inc
GRALUnknown0.53% - 48
HCA Healthcare Inc
HCAUnknown0.53% - 49
Travere Therapeutics Inc
TVTXUnknown0.52% - 50
Molina Healthcare Inc
MOHUnknown0.52% - 51
Tenet Healthcare Corp
THCUnknown0.51% - 52
Adaptive Biotechnologies Corp
ADPTUnknown0.50% - 53
Ideaya Biosciences Inc
IDYAUnknown0.49% - 54
Medpace Holdings Inc
MEDPUnknown0.49% - 55
Krystal Biotech Inc
KRYSUnknown0.47% - 56
Dexcom Inc
DC4Unknown0.47% - 57
Edgewise Therapeutics Inc
EWTXUnknown0.45% - 58
Halozyme Therapeutics Inc
HALOUnknown0.45% - 59
Danaher Corp
DHRUnknown0.45% - 60
Avidity Biosciences Inc
RNAUnknown0.44% - 61
Janux Therapeutics Inc
JANXUnknown0.44% - 62
Axsome Therapeutics Inc
AXSMUnknown0.42% - 63
Crinetics Pharmaceuticals Inc
CRNXUnknown0.41% - 64
Rhythm Pharmaceuticals Inc
RYTMUnknown0.40% - 65
Geron Corp
GONUnknown0.39% - 66
Teva Pharmaceutical Industries Ltd
TEVAUnknown0.38% - 67
Boston Scientific Corp
BSXUnknown0.35% - 68
Tandem Diabetes Care Inc
TNDMUnknown0.34% - 69
Nuvalent Inc
NUVLUnknown0.32% - 70
Alkermes PLC
ALKSUnknown0.31% - 71
Vir Biotechnology Inc
VIRUnknown0.30% - 72
Personalis Inc
PSNLUnknown0.28% - 73
Incyte Corp
INCYUnknown0.27% - 74
Newamsterdam Pharma Co NV
NAMSUnknown0.26% - 75
Merus NV
MRUSUnknown0.25% - 76
McKesson Corp
MCKUnknown0.24% - 77
Praxis Precision Medicines Inc
PRAXUnknown0.24% - 78
Stryker Corp
SYKUnknown0.23% - 79
Sera Prognostics Inc
SERAUnknown0.23% - 80
Xencor Inc
XNCRUnknown0.21% - 81
Structure Therapeutics Inc
GPCRUnknown0.21% - 82
Scholar Rock Holding Corp
SRRKUnknown0.20% - 83
Cidara Therapeutics Inc
CDTXUnknown0.19% - 84
Insulet Corp
PODDUnknown0.13% - 85
EyePoint Pharmaceuticals Inc
EYPTUnknown0.09% - 86
TScan Therapeutics Inc
TCRXUnknown0.07% - 87
Pyxis Oncology Inc
PYXSUnknown0.06% - 88
Rallybio Corp
RLYBUnknown0.05% - 89
Novavax Inc
NVV1Unknown0.03% - 90
CONTRA CHINOOK THERAPE
Unknown0.02% - 91
169CVR016
169CVR016Unknown0.02% - 92
Sutro Biopharma Inc
STROUnknown0.00% - 93
I-Mab
IMABUnknown0.00% - 94
Mural Oncology PLC
MURAUnknown0.00% - 95
CONTRA FUSION PHARMACE
Unknown0.00% - 96
361CVR012
361CVR012Unknown0.00% - 97
Galera Therapeutics Inc
GRTXUnknown0.00% - 98
881CVR013
881CVR013Unknown0.00% - 99
TETRAPHASE PHARMACEUTICALS INC
Unknown0.00% - 100
CONTRA SPECTRUM PHARMA
Unknown0.00% - 101
847CVR016
847CVR016Unknown0.00% - 102
000000000
000000000Unknown-0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 6.443% | ||
| 2 | Amgen Inc | AMGN | 5.972% | ||
| 3 | Regeneron Pharmaceuticals Inc | REGN | 5.908% | ||
| 4 | Vertex Pharmaceuticals Inc | VRTX | 3.956% | ||
| 5 | Eli Lilly & Co | LLY | 3.571% | ||
| 6 | BioMarin Pharmaceutical Inc | BMRN | 2.921% | ||
| 7 | Alnylam Pharmaceuticals Inc | ALNY | 2.773% | ||
| 8 | UnitedHealth Group Inc | UNH | 2.773% | ||
| 9 | State Street Global Advisors | GVMXX | 2.229% | ||
| 10 | Abbott Laboratories | ABT | 2.046% | ||
| 11 | BioNTech SE | BNTX | 2.024% | ||
| 12 | Argenx SE | ARGX | 1.836% | ||
| 13 | Sarepta Therapeutics Inc | SRPT | 1.806% | ||
| 14 | Summit Therapeutics Inc | SMMT | 1.701% | ||
| 15 | Insmed Inc | IM8N | 1.692% | ||
| 16 | AbbVie Inc | ABBV | 1.633% | ||
| 17 | Ascendis Pharma A/S | ASND | 1.482% | ||
| 18 | Thermo Fisher Scientific Inc | TMO | 1.412% | ||
| 19 | Medtronic PLC | MDT | 1.329% | ||
| 20 | Neurocrine Biosciences Inc | NBIX | 1.329% | ||
| 21 | Intuitive Surgical Inc | ISRG | 1.238% | ||
| 22 | Cytokinetics Inc | CYTK | 1.207% | ||
| 23 | Merck & Co Inc | MRK | 1.204% | ||
| 24 | Illumina Inc | ILMN | 1.195% | ||
| 25 | uniQure NV | QURE | 1.178% | ||
| 26 | Ultragenyx Pharmaceutical Inc | RARE | 1.133% | ||
| 27 | Becton Dickinson & Co | BDX | 1.117% | ||
| 28 | Elevance Health Inc | ELV | 1.055% | ||
| 29 | Immunovant Inc | IMVT | 1.000% | ||
| 30 | AstraZeneca PLC | AZN | 0.985% | ||
| 31 | Akero Therapeutics Inc | AKRO | 0.927% | ||
| 32 | Tempus AI Inc | TEM | 0.857% | ||
| 33 | Xenon Pharmaceuticals Inc | XENE | 0.847% | ||
| 34 | Ionis Pharmaceuticals Inc | ISI | 0.838% | ||
| 35 | Oculis Holding AG | OCS | 0.814% | ||
| 36 | Zoetis Inc | ZTS | 0.786% | ||
| 37 | Inspire Medical Systems Inc | INSP | 0.762% | ||
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 0.693% | ||
| 39 | Arcutis Biotherapeutics Inc | ARQT | 0.649% | ||
| 40 | Amylyx Pharmaceuticals Inc | AMLX | 0.628% | ||
| 41 | Denali Therapeutics Inc | DNLI | 0.604% | ||
| 42 | Vaxcyte Inc | PCVX | 0.592% | ||
| 43 | Bristol-Myers Squibb Co | BMY | 0.579% | ||
| 44 | Guardant Health Inc | GH | 0.577% | ||
| 45 | ARS Pharmaceuticals Inc | SPRY | 0.573% | ||
| 46 | Sionna Therapeutics Inc | SION | 0.566% | ||
| 47 | GRAIL Inc | GRAL | 0.532% | ||
| 48 | HCA Healthcare Inc | HCA | 0.525% | ||
| 49 | Travere Therapeutics Inc | TVTX | 0.520% | ||
| 50 | Molina Healthcare Inc | MOH | 0.519% | ||
| 51 | Tenet Healthcare Corp | THC | 0.509% | ||
| 52 | Adaptive Biotechnologies Corp | ADPT | 0.496% | ||
| 53 | Ideaya Biosciences Inc | IDYA | 0.493% | ||
| 54 | Medpace Holdings Inc | MEDP | 0.493% | ||
| 55 | Krystal Biotech Inc | KRYS | 0.469% | ||
| 56 | Dexcom Inc | DC4 | 0.466% | ||
| 57 | Edgewise Therapeutics Inc | EWTX | 0.455% | ||
| 58 | Halozyme Therapeutics Inc | HALO | 0.451% | ||
| 59 | Danaher Corp | DHR | 0.445% | ||
| 60 | Avidity Biosciences Inc | RNA | 0.439% | ||
| 61 | Janux Therapeutics Inc | JANX | 0.436% | ||
| 62 | Axsome Therapeutics Inc | AXSM | 0.419% | ||
| 63 | Crinetics Pharmaceuticals Inc | CRNX | 0.412% | ||
| 64 | Rhythm Pharmaceuticals Inc | RYTM | 0.397% | ||
| 65 | Geron Corp | GON | 0.390% | ||
| 66 | Teva Pharmaceutical Industries Ltd | TEVA | 0.381% | ||
| 67 | Boston Scientific Corp | BSX | 0.346% | ||
| 68 | Tandem Diabetes Care Inc | TNDM | 0.343% | ||
| 69 | Nuvalent Inc | NUVL | 0.320% | ||
| 70 | Alkermes PLC | ALKS | 0.310% | ||
| 71 | Vir Biotechnology Inc | VIR | 0.301% | ||
| 72 | Personalis Inc | PSNL | 0.281% | ||
| 73 | Incyte Corp | INCY | 0.268% | ||
| 74 | Newamsterdam Pharma Co NV | NAMS | 0.257% | ||
| 75 | Merus NV | MRUS | 0.248% | ||
| 76 | McKesson Corp | MCK | 0.241% | ||
| 77 | Praxis Precision Medicines Inc | PRAX | 0.240% | ||
| 78 | Stryker Corp | SYK | 0.234% | ||
| 79 | Sera Prognostics Inc | SERA | 0.232% | ||
| 80 | Xencor Inc | XNCR | 0.214% | ||
| 81 | Structure Therapeutics Inc | GPCR | 0.210% | ||
| 82 | Scholar Rock Holding Corp | SRRK | 0.199% | ||
| 83 | Cidara Therapeutics Inc | CDTX | 0.191% | ||
| 84 | Insulet Corp | PODD | 0.132% | ||
| 85 | EyePoint Pharmaceuticals Inc | EYPT | 0.091% | ||
| 86 | TScan Therapeutics Inc | TCRX | 0.072% | ||
| 87 | Pyxis Oncology Inc | PYXS | 0.065% | ||
| 88 | Rallybio Corp | RLYB | 0.052% | ||
| 89 | Novavax Inc | NVV1 | 0.025% | ||
| 90 | CONTRA CHINOOK THERAPE | - | 0.022% | ||
| 91 | 169CVR016 | 169CVR016 | 0.022% | ||
| 92 | Sutro Biopharma Inc | STRO | 0.005% | ||
| 93 | I-Mab | IMAB | 0.005% | ||
| 94 | Mural Oncology PLC | MURA | 0.002% | ||
| 95 | CONTRA FUSION PHARMACE | - | 0.001% | ||
| 96 | 361CVR012 | 361CVR012 | 0.001% | ||
| 97 | Galera Therapeutics Inc | GRTX | 0.001% | ||
| 98 | 881CVR013 | 881CVR013 | 0.000% | ||
| 99 | TETRAPHASE PHARMACEUTICALS INC | - | 0.000% | ||
| 100 | CONTRA SPECTRUM PHARMA | - | 0.000% | ||
| 101 | 847CVR016 | 847CVR016 | 0.000% | ||
| 102 | 000000000 | 000000000 | -0.001% |